Financings for Jan. 16, 2024 Jan. 16, 2024 No Comments Biopharmas raising money in public or private financings, including: Alto, Cyrano, Defence, Delsitech, Disco, Prota, Stalicla, Vaxart, Xortx.Read More
Financings for Jan. 16, 2024 Jan. 16, 2024 No Comments Biopharmas in Asia-Pacific raising money in public or private financings: Ji Xing.Read More
Financings for Jan. 12, 2024 Jan. 12, 2024 No Comments Biopharmas raising money in public or private financings, including: Dyne.Read More
Financings for Jan. 12, 2024 Jan. 12, 2024 No Comments Med-tech firms raising money in public or private financings, including: Rune Labs.Read More
Financings for Jan. 11, 2024 Jan. 11, 2024 No Comments Biopharmas raising money in public or private financings, including: Clearmind, Inventiva, Nodus, Praxis.Read More
Financings for Jan. 11, 2024 Jan. 11, 2024 No Comments Med-tech firms raising money in public or private financings, including: Desicionrx.Read More
Neurology/Psychiatric Myrobalan to use series A funding for CNS neurorestorative therapies Jan. 11, 2024 No Comments Myrobalan Therapeutics Inc. has completed a $24 million series A funding to support development of neurorestorative therapies for CNS diseases.Read More
Financings for Jan. 10, 2024 Jan. 10, 2024 No Comments Biopharmas raising money in public or private financings, including: Bolden, Catalyst, Maps, Mimivax, Myrobalan, Opko.Read More
Financings for Jan. 10, 2024 Jan. 10, 2024 No Comments Med-tech firms raising money in public or private financings, including: Via Scientific, Whispersom.Read More
Financings for Jan. 9, 2024 Jan. 9, 2024 No Comments Biopharmas raising money in public or private financings, including: Acousia, Biosenic, Jixing, Keros, Kymera, Longboard, Zealand.Read More